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Effects of vitamin D and the antimicrobial peptide in asthma  
 
INTRODUCTION 
In the last years, it has been recognized that in 
addition to the classical role of vitamin D in 
calcium and bone homeostasis, Vitamin D 
modulates a variety of processes and regulatory 
systems including host defense, inflammation, 
immunity, and repair. Several lung diseases, all 
inflammatory in nature, may be related to activities 
of Vitamin D including asthma and COPD1. 
Vitamin D deficiency has been blamed as one 
causes of increased asthma prevalence in the last 
decades2. The underlying mechanisms how Vitamin 
D modulates the pathogenesis of asthma is not 
clear. Vitamin D may modulate the function of 
various immune cells such as B- and T-
lymphocytes3. Interestingly, application of Vitamin 
D is potentially capable to overcome the poor 
glucocorticoid responsiveness in severe asthmatics 
by upregulation of IL-10 production from CD4+ T 
cell4. 
Vitamin D–mediated innate immunity, 
particularly through enhanced expression of the 
human cathelicidin antimicrobial peptide (hCAP-
18), is important in host defenses against 
respiratory tract pathogens5. 
Increased levels of high sensitivite-C reactive 
protien (Hs-CRP) were found to be significantly 
associated with respiratory function impairment and 
bronchial hyperresponsiveness (BHR)6,7, suggesting 
that systemic inflammation may be associated with 
respiratory impairment and that Hs-CRP might be a 
sensitive marker for severe asthma. 
 
Original article 
Background: Vitamin D modulates a variety of processes and 
regulatory systems including host defense, inflammation, and 
immunity. A connection between Vitamin D status and asthma has 
been considered. Vitamin D mediates innate immunity, particularly 
through enhanced expression of the human cathelicidin 
antimicrobial peptide (LL-37). Increased levels of high sensitive-C 
reactive protein (Hs-CRP) were found to be significantly associated 
with respiratory function impairment. Objective: to evaluate the 
relation between serum vitamin D, Hs-CRP and LL-37 levels and 
asthma. Study design: Thirty children (15 males and 15 females) 
with proven diagnosis of asthma (ages ranged from 3-13 years) were 
studied; they attended the pediatric department of Zagazig 
University Hospital in the year 2011. In addition, 30 age and sex 
matched apparently healthy children served as a control group. All 
children were subjected to history taking, clinical examination, 
laboratory investigations (CBC, CRP, ESR), determination of serum 
level of 25-hydroxyvitamin D (25 OHD) and plasma LL-37. Results: 
The study revealed a highly significant decrease in 25 OHD, LL-37 
and a highly significant increase in Hs-CRP in children with asthma 
than in control group. There were a highly significant positive 
correlation between vitamin D and LL37 in patients' and control 
groups and a significant negative correlation between both 25OHD 
and LL37 and Hs-CRP in patients' group. High WBC count 
(specially neutrophils and lymphocytes), Hs-CRP level and low 
levels of hemoglobin, 25OHD and LL 37 in patient group were 
considered risk factors of asthma. Conclusion: Inappropriate 
concentration of vitamin D decreases the ability of the immune 
system to defend against infection through lowering LL-37 and 
elevated Hs-CRP which leads to occurrence and precipitation of 
asthma.  
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Aim of the work 
To evaluate the relation between serum vitamin D, 
Hs-CRP and LL-37 levels and asthma. 
 
METHODS 
This case control study included 30 children (15 
male and 15 female) with proven diagnosis of 
asthma. Their ages ranged from 3-13 years (X±SD: 
7.37±3.10 years) and were attending Pediatric 
Clinic, Zagazig University Hospital during the year 
2011. They were selected randomly one every three 
cases and were divided into 4 subgroups according 
to GINA guidelines8. 
1. Mild intermittent (12 children, 6 males & 6 
females). 
2. Mild persistent (10 children, 5 males & 5 
females). 
3. Moderate persistent (6 children, 2 males & 4 
females). 
4. Severe persistent (2 male children). 
Thirty healthy children (16 males, 14 females) of 
ages ranging from 2-13 years with a mean of (7.10 
± 2.94 y) were studied as a control group. Ethical 
approval was obtained from the local research 
ethics committee and parents of all children gave an 
informed written consent prior to the study. 
All children were subjected to the following: 
1. History taking including age, sex, residence, 
socioeconomic level, cough, chest tightness. 
2. Clinical examination including a transverse 
crease on the nose, conjunctival congestion and 
inflammation, tachypnea, subcostal, intercostal 
retraction, barrel-shaped chest, prolonged 
expiration, rhonchi, wheezes, tachycardia. 
3.  Complete blood count (CBC) done on Sysmex 
SF3000 cell counter (Seimens, Germany). 
4. High sensitive-CRP determination. Serum 
concentrations of high-sensitive CRP were 
measured using an automated nephelometric 
method (BN ProSpec, Seimens, Germany); it is 
a closed system analyzer with its specially 
manufactured kits from the same company. Hs-
CRP levels ≥6 mg/L were considered as 
increased9. 
5. Measurement of serum 25-OH vitamin D: 2 ml 
venous blood sample was obtained, centrifuged 
and serum was separated and stored at -20ºC 
until assayed. Serum levels of 25-OH vitamin D 
were measured after extraction using the 
Immunodiagnostic Enzyme-Immuno-Assay 
(EIA) developed by Immundiagnostic, 
Bensheim and Biomedica, Wien, Australia10. 
Catalog number 02082005 25 OH vit D6.DOC. 
The cut off level of vitamin D was 35 nmol/l. 
6. Measurement of human plasma LL-37: 2 ml 
venous blood samples were collected on EDTA, 
centrifuged and plasma was separated. The 
plasma stored at -70ºC in polypropylene tubes 
until assay. The human LL-37 was measured 
using solid-phase enzyme linked immunosorbent 
assay (ELISA) based on the sandwich principle 
using a commercial human LL-37 ELISA kit, 
HK321 Hycult Biotech, Fronststraat 2a,5405PB 
Uden, the Netherlands11. The cut off level of LL 
37 was 20 ng/ml. 
Statistical analysis: 
Data were presented as mean±standard deviation 
(X±SD) or percentage (%). The means of two 
groups were compared using student "t" test. Chi 
square (χ2) was used to find the association between 
row and column variables. Linear correlation and 
regression were used to test the correlation between 
the measured parameters and the studied groups. 
Odds ratio was used to quantify the risk. Cut off 
values were calculated from the ROC curve as 
mean±2SD of control. Data were tabulated and 
statistically analyzed with the statistical package for 
Social Sciences (SPPS), version 10 software. P-
values less than 0.05 were considered significant12. 
 
RESULTS 
Analysis of demographic characteristics of the 
studied groups revealed that there were 
nonsignificant differences between patients and 
controls as regard age, sex, weight and residence 
(table 1). Table 2 shows the clinical and 
radiological presentations of the patient group. 
Cough and rhonchi were the most presenting 
symptoms and signs respectively. Table 3 shows 
the laboratory data of studied groups. No statistical 
significance was obtained between the two groups 
as regard white blood cell count, hemoglobin level 
and platelet count. 
Our study showed a highly significant decrease 
in 25OHD, LL-37 and a highly significant increase 
in Hs-CRP in children with asthma than in control 
group (table 4). The lowest levels of 25OHD, LL-
37 and highest level of Hs-CRP were found in 
patients with moderate persistent and severe 
persistent asthma (table 5). There was a highly 
significant positive correlation between 25OHD and 
LL37 in patients, control groups and a significant 
negative correlation between both 25OHD and 
LL37 and Hs-CRP in patients group (table 6). High 
WBC count (specially neutrophils and 
lymphocytes) and Hs-CRP level and low levels of 
hemoglobin, 25OHD, LL 37 in patients' group were 
considered risk factors of asthma (table 7). 
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Table 1. Demographic characteristics of the studied groups. 
Variables 
Patients 
(n = 30) 
Controls  
(n = 30) t / 2 p 
Age (years)  
X±SD 
7.37 ± 3.10 7.10 ± 2.94 0.342 0.734 
Weight 23.03 ± 7.50 22.13 ± 6.33 0.502 0.618 























Table 2. Clinical and radiological presentations of the patients' group. 
 No % 
Symptoms: 
1.Cough 28 93.3 
2.Wheezes 15 50 
3.Chest tightness 8 26.7 




1.Tachypnea 5 16.7 
2.Prolonged expiration 10 33.3 
3.Tachycardia 5 16.7 
4.Rhonchi 21 70 
5.Barrel-shaped chest 3 10 
6.Chest x-ray 1 3.3 
7. Other signs (which includes, a transverse crease on the nose, conjunctival 




Table 3. Laboratory data of the studied groups. 
Variables 
Patients 








White Blood cell count 
 (x103/mm3) 
9.45 ± 3.72 
 (5 – 17)    
7.95 ± 1.79 




11.50 ± 1.21 
(8.9 – 13) 
11.31 ± 0.90 
(10 – 13) 
0.700 0.487 
Platelet count  
(x103/mm3) 
313.00 ± 62.54 
(160 – 450)  
332.00 ± 47.15 





Table 4. 25-OH Vitamin D, LL-37 and Hs-CRP levels among the studied groups. 






< 0.001* 6.955 181.87 ± 90.38 62.97 ± 24.50 25-OH Vitamin D (nmol/l) 
< 0.001* 6.571 11.59 ± 4.45 5.80 ± 1.89 LL-37 (ng/ml) 
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Table 5. Relation between 25-OH vitamin D, LL-37 and Hs-CRP levels and the severity of asthma. 
Variables Mild intermittent 
and mild 
persistent asthma 





(n = 8) 
t p 
25-OH Vitamin D (nmol/l) 69.36 ± 25.56 45.38 ± 6.70 4.038 < 0.001* 
LL-37(ng/ml) 6.47 ± 1.82 4.69 ± 0.47 4.222 < 0.001* 
Hs-CRP (mg/l) 6.10 ± 1.09 7.85 ± 2.59 1.846 0.103 
 
 
Table 6. Correlations among the studied laboratory parameters. 
  LL-37 Hs-CRP 
r p r p 
25-OH Vitamin D 
Control 0.465 0.010* 0.253 0.178 
Patients 0.526 0.003* - 0.335 0.070 
LL-37 
Control   0.372 0.043* 
Patients   - 0.138 0.466 
 
 
Table 7: Risk factors for the development of asthma 
 Patients 
(n = 30) 
Control  





















































































(2.101 – 5.209)* 
 
DISCUSSION 
Vitamin D insufficiency is widespread and is 
associated with increased incidence of respiratory 
tract infections and asthma. This association may be 
particularly important for individuals with asthma, 
for whom respiratory tract infections often trigger 
asthma exacerbation and may increase the 
frequency, severity, and duration of lower 
respiratory tract symptoms13. Our study showed that 
there were nonsignificant differences between 
patients and controls regarding age, sex and 
associates residence. Kosti, et al,14 declared that 
children living in athens had higher likelihood of 
asthma compared with children living in rural areas 
this may be due to the higher age of patients of this 
study. 
The commonest complaint in our study was 
cough (93.3%). As stated by Castro-Rodríguez, et 
al,15 cough may be the only symptom of asthma. 
Also 50% of our patients had wheezes which is one 
of the most common symptoms of asthma16. In this 
study there were nonsignificant differences between 
patients and controls regarding white blood cell 
count, hemoglobin level and platelets count. 
In our series, asthmatic patients had 
significantly lower 25OHD levels than controls. A 
connection between vitamin D deficiency and 
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asthma has been considered since many years. Low 
levels of serum vitamin D is associated with 
impaired pulmonary function, increased incidence 
of inflammatory and infectious diseases. The exact 
mechanisms underlying these data appear to impact 
on the function of inflammatory and structural cells, 
including dendritic cells, lymphocytes, monocytes, 
and epithelial cells17. Ginde, et al,18 added that the 
association between serum Vitamin D level and 
upper respiratory infection was much stronger 
among individuals with asthma compared with 
those without asthma. This increased risk of 
respiratory infections may contribute to incident 
wheezing illness in children and cause asthma 
exacerbations. There may be a cause-and-effect 
relationship between vitamin D deficiency and the 
increased incidence of asthma because vitamin D 
deficiency is associated with increased airway 
hyperresponsiveness, lower pulmonary functions, 
worse asthma control, and possibly steroid 
resistance19. In addition lung epithelial cells express 
high baseline levels of 1α-hydroxylase. This allows 
the conversion of inactive calcidiol to active 
calcitriol locally within the lung. Calcitriol has been 
shown to inhibit the synthesis and release of certain 
cytokines, such as platelet-derived growth factor, 
and matrix metalloproteinases, from bronchial 
smooth muscle cells, thereby leading to decreased 
lung inflammation and smooth muscle cell 
proliferation. Also Vitamin D increases synthesis of 
interleukin 10 by CD4_CD25_Foxp3_ T-regulatory 
cells and dendritic cells, while concurrently 
inhibiting dendritic cell activation by down 
regulating expression of co-stimulatory molecules 
CD40 and CD80/8620.  
Our results showed significant correlation 
between low 25 OHD level and the severity of 
asthma. These were in agreement with Brehm, et 
al,21 who found that children with lower vitamin D 
levels were significantly more likely to have been 
hospitalized for asthma, tended to have airways 
with increased hyperreactivity and were likely to 
have used more inhaled corticosteroids, all 
signifying higher asthma severity. Vitamin D 
deficiency increases the risk of severe asthma 
exacerbation and the need for emergency 
department evaluation or hospitalization; it may be 
related to asthma severity in several ways. First, 
vitamin D influences the immune system through 
its effects on helper T cell type 1 and type 2, and 
regulatory T cells. Second, current vitamin D intake 
may influence lung function in patients with 
asthma, similar to its potential effects in non-
asthmatics. Third, vitamin D stimulation has been 
shown to influence micro array gene expression 
signatures in bronchial smooth muscle cells. Fourth, 
polymorphisms in the gene encoding the vitamin D 
receptor (VDR) have been associated with asthma 
phenotypes, none of these polymorphisms resulted 
in an amino acid change in the translated protein, so 
the mechanism of increased asthma susceptibility is 
related to regulation of VDR expression22. 
In our study LL-37 levels were significantly 
lower in patients than controls and there was a 
significant correlation between low LL-37 levels 
and the severity of asthma. Vitamin D–mediated 
innate immunity, particularly through enhanced 
expression of the human cathelicidin antimicrobial 
peptide (LL-37), is important in host defenses 
against respiratory tract pathogens which precipitate 
asthma18. In addition, Xiao et al,23 showed that 
patients with asthma show a dramatic decrease of 
LL-37. 
We found a highly significant positive 
correlation between LL-37 and 25OHD. Vitamin D 
stimulate the secretion of natural antibiotics known 
as antimicrobial peptides (LL-37), this gives 
vitamin D the potential to combat a range of 
infections24. It regulates the production of 
antimicrobial peptides such as LL-37 in cultured 
macrophages25. Also Jeng, et al,26 found a positive 
association between vitamin D status and plasma 
LL-37, which suggests that systemic LL-37 levels 
may be regulated by vitamin D status. In addition 
Camargo, et al,20 found an association between 
lower blood vitamin D levels and increased 
respiratory infection, increased wheezing, and 
decreased LL-37 levels. So the human cathelicidin 
(LL-37) appears to have a particularly important 
role in the vitamin D–mediated mechanism against 
infection. 
In our study Hs-CRP levels were significantly 
higher in patients than controls. Jousilahti, et al,27 
stated that in asthma, beside the importance of 
airway inflammation, systemic inflammation may 
exist based on the increased serum Hs-CRP levels. 
Increased levels of Hs-CRP were found to be 
significantly associated with respiratory function 
impairment and bronchial hyperresponsiveness. Hs-
CRP is a sensitive marker for inflammation, 
infection and tissue damage, and contributes to the 
host defense against infection by activating the 
complement pathway. A positive association has 
been reported between raised Hs-CRP levels, 
asthma, respiratory impairment and bronchial 
hyper-reactivity28.  
 Our study showed a significant negative 
correlation between both 25OHD and LL37 and Hs-
CRP in the patients group. Ford,29 found a positive 
correlation between raised CRP levels and asthma, 
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respiratory impairment and bronchial 
hyperresponsiveness. Whereas Devaraj, et al,30 
reported a correlation of peripheral blood CRP 
levels with severity, extent, and progression of 
inflammatory pathology.  
The present study showed that high WBC 
count, low hemoglobin level, low vitamin D level, 
low LL-37 level and high Hs-CRP level were risk 
factors of asthma. Low vitamin D level was the 
most important risk factor.  
In conclusion, inappropriate concentration of 
vitamin D decreases the ability of the immune 
system to defend against infection through lowering 
LL-37 and elevated Hs-CRP which leads to 
occurrence and precipitation of asthma. So, we 
recommend appropriate vitamin D supplementation 
and sun exposure to decrease occurrence of asthma 
and its severity and performing further studies to 
define the correlation between vitamin D, LL-37, 
Hs-CRP and asthma, also study the role of vitamin 
D as a therapeutic agent in the treatment of asthma. 
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